Viewing Study NCT06031558


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2025-12-29 @ 2:28 PM
Study NCT ID: NCT06031558
Status: RECRUITING
Last Update Posted: 2023-09-21
First Post: 2023-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC
Sponsor: Shouyao Holdings (Beijing) Co. LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module